Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
about
Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibitionNickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer.Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation.A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers.Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.Selection and characterization of a human ovarian cancer cell line resistant to auranofin.Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination.The harsh microenvironment in infarcted heart accelerates transplanted bone marrow mesenchymal stem cells injury: the role of injured cardiomyocytes-derived exosomes.Developing a genetic signature to predict drug response in ovarian cancer.Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug repositionPlanarians as models to investigate the bioactivity of gold(I) complexes in vivoThioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells
P2860
Q33801982-5926687E-6493-438C-BD4C-C67E00DA823BQ37440054-4A7BBF4C-977A-4BC5-A09A-485BB1415A3EQ37745339-75B60645-432E-4D79-A34E-4F96F290E64CQ41335233-30FF1C2C-42C1-4F46-BDD0-3BFE375D83EEQ42362660-0AF48F99-81BD-423D-9B95-A207F4AF672BQ47098444-39C20FC9-34F2-4451-A5B3-C58C353A8F28Q47135396-86430E0E-3E3D-44F2-B455-F864CE39E9AEQ48529877-408A7787-0363-4AFB-867A-BC3A15A53888Q52676432-A326F643-DB70-4ADE-BDB1-9ACB2B224889Q55028564-BCA68CD1-4630-454C-86E4-7D1E111278DEQ57163862-02FB2331-042E-48CF-8972-36EBC6FCD226Q58577738-2ECA3BFE-0820-4D40-BB58-691440294C84Q59134245-A45A51D3-BD72-4519-BFE9-4ED7A38ED8AE
P2860
Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Two clinical drugs deubiquitin ...... effects in vitro and in vivo.
@ast
Two clinical drugs deubiquitin ...... effects in vitro and in vivo.
@en
type
label
Two clinical drugs deubiquitin ...... effects in vitro and in vivo.
@ast
Two clinical drugs deubiquitin ...... effects in vitro and in vivo.
@en
prefLabel
Two clinical drugs deubiquitin ...... effects in vitro and in vivo.
@ast
Two clinical drugs deubiquitin ...... effects in vitro and in vivo.
@en
P2093
P2860
P356
P1433
P1476
Two clinical drugs deubiquitin ...... effects in vitro and in vivo.
@en
P2093
Changshan Yang
Chong Zhao
Hongbiao Huang
Huidan Long
Jianyu Cai
Jinbao Liu
Ningning Liu
Xianliang Hua
P2860
P304
P356
10.18632/ONCOTARGET.6425
P407
P50
P577
2015-11-28T00:00:00Z